These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7839379)

  • 21. Acadesine: a unique cardioprotective agent for myocardial ischemia.
    Nawarskas JJ
    Heart Dis; 1999; 1(4):255-60. PubMed ID: 11720632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microvascular and neuronal consequences of common carotid artery thrombosis and platelet embolization in rats.
    Dietrich WD; Prado R; Halley M; Watson BD
    J Neuropathol Exp Neurol; 1993 Jul; 52(4):351-60. PubMed ID: 8355024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An improved photochemical model of embolic cerebral infarction in rats.
    Futrell N
    Stroke; 1991 Feb; 22(2):225-32. PubMed ID: 1825897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of acadesine on myocardial ischaemia in patients with coronary artery disease.
    de Jonge R; Macleod DC; Suryapranata H; van Es GA; Friedman J; Serruys PW; de Jong JW
    Eur J Pharmacol; 1997 Oct; 337(1):41-4. PubMed ID: 9389379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acadesine, an adenosine-regulating agent with the potential for widespread indications.
    Drew BG; Kingwell BA
    Expert Opin Pharmacother; 2008 Aug; 9(12):2137-44. PubMed ID: 18671468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury.
    Mullane K
    Cardiovasc Res; 1993 Jan; 27(1):43-7. PubMed ID: 8458030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina.
    Holdright DR; Sparrow JL; Wright CL; Steiner J; Fox KM
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):193-7. PubMed ID: 7918131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acadesine lowers temporal threshold for the myocardial infarct size limiting effect of preconditioning.
    Tsuchida A; Liu GS; Mullane K; Downey JM
    Cardiovasc Res; 1993 Jan; 27(1):116-20. PubMed ID: 8458021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model.
    Thiagarajan P; Benedict CR
    Circulation; 1997 Oct; 96(7):2339-47. PubMed ID: 9337209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of nitric oxide synthase inhibition on acute platelet accumulation and hemodynamic depression in a rat model of thromboembolic stroke.
    Stagliano NE; Zhao W; Prado R; Dewanjee MK; Ginsberg MD; Dietrich WD
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1182-90. PubMed ID: 9390650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet emboli in rat brain cross when the contralateral carotid artery is occluded.
    Tietjen GE; Futrell N; Garcia JH; Millikan C
    Stroke; 1991 Aug; 22(8):1053-8. PubMed ID: 1866753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin content of carotid thrombi alters the production of embolic stroke in the rat.
    Halvorsen AM; Futrell N; Wang LC
    Stroke; 1994 Aug; 25(8):1632-6. PubMed ID: 8042216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acadesine reduces the frequency of coronary artery reocclusion following rt-PA induced thrombolysis in the dog.
    Young MA; Henry C; Wong S; Bullough D; Mullane K
    Thromb Haemost; 1995 Nov; 74(5):1348-52. PubMed ID: 8607121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart.
    Galiñanes M; Zhai X; Bullough D; Mullane KM; Hearse DJ
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):752-61. PubMed ID: 7564443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Y-20811, a thromboxane synthetase inhibitor, on photochemically induced cerebral embolism in rabbits.
    Fujimura M; Mikashima H
    Thromb Res; 1993 May; 70(3):233-44. PubMed ID: 8327988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.
    Bullough DA; Zhang C; Montag A; Mullane KM; Young MA
    J Clin Invest; 1994 Oct; 94(4):1524-32. PubMed ID: 7929829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin release into plasma during common carotid artery thrombosis in rats.
    Wester P; Dietrich WD; Prado R; Watson BD; Globus MY
    Stroke; 1992 Jun; 23(6):870-5. PubMed ID: 1595108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of MK-801 to reduce infarct volume in thrombotic middle cerebral artery occlusion in rats.
    Yao H; Ginsberg MD; Watson BD; Prado R; Dietrich WD; Kraydieh S; Busto R
    Stroke; 1993 Jun; 24(6):864-70; discussion 870-1. PubMed ID: 8506558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats.
    Sereghy T; Overgaard K; Boysen G
    Stroke; 1993 Nov; 24(11):1702-8. PubMed ID: 8236347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acadesine (AICA-riboside): disposition and metabolism of an adenosine-regulating agent.
    Dixon R; Fujitaki J; Sandoval T; Kisicki J
    J Clin Pharmacol; 1993 Oct; 33(10):955-8. PubMed ID: 8227467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.